Back to results
US 10,307,359 B2Granted
Topical dihydrotestosterone (DHT) for promoting hair growth-containing formulations
OwnerEdward Dunne Corboy, Jr.inventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to the composition and method of use for the topical application of the potent androgen hormone dihydrotestosterone (DHT), used alone or in fixed combination with other hair growth medications; including other androgens, bimatoprost, other prostamides, prostaglandins, minoxidil or apocrine hair growth factors to promote and enhance hair growth of terminal mustache hair, beard hair, also chest hair, and other male androgen sensitive or dependent hair growth in humans or animals.
Claims14
A method for promoting or enhancing facial hair growth, comprising
- topically administering an effective amount of a pharmaceutically acceptable formulation of dihydrotestosterone to a target skin area, which is the mustache region, beard region, or both of an adult human male, who has completed puberty, and who is unable to grow full beards and/or mustaches, and wherein the target skin area has sparse mature terminal hair and the human male has a level of circulating total serum testosterone that is within a normal physiologic reference range, thereby promoting or enhancing growth of mature terminal hair at the target skin area.
A method for promoting or enhancing facial hair growth, comprising
- topically administering an effective amount of a pharmaceutically acceptable formulation of dihydrotestosterone to a target skin area, or areas, of the mustache region, beard region, or both of an adult human male, who has completed puberty, who is unable to grow a robust and full beard and/or mustache, wherein the target skin area, or areas, has or have sparse mature terminal hair growth and the human male does not suffer from below normal levels of circulating total serum testosterone, thereby promoting or enhancing growth of mature terminal hair at the target skin area, or areas;
- and wherein the dihydrotestosterone is targeted to the hair shaft and the hair follicle structures with the goal of dihydrotestosterone delivery to the hair follicle bulbs and mesenchymal dermal papilla cells located in the hair follicle bulb area, with minimal drug reaching the systemic circulation.
Dependencies are inferred from the claim text.